Novartis registers new ISA vaccine for Chile

Novartis Chile S.A., a Chilean affiliate of the Swiss-based pharmaceutical company Novartis AG, has secured the registry in Chile for its vaccine to prevent the infectious salmon anemia (ISA) virus.